Sept 28 (Reuters) – Summit Therapeutics said on Monday that British drugmaker AstraZeneca would invest $2 billion in the company and collaborate on a series of studies testing their cancer treatments
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 29 (Reuters) - Cochlear Limited: * CONFIRMS THAT IT HAS RECEIVED A CLASS ACTION…
Sept 28 (Reuters) - Jefferies Financial beat third-quarter profit estimates on Monday, as higher fees…
By Anzar Mehraj Sept 28 (Reuters) - Anthropic will not appear before an Australian senate…
IRAN'S FOREIGN MINISTER ARAQCHI SAYS TEHRAN DISCUSSED WITH QATARI MEDIATORS IDEAS ON HOW TO FULFIL…
VIDEO SHOWS: ARCHIVE FOOTAGE OF FIFA HEADQUARTERS, FIFA PRESIDENT INFANTINO, UEFA PRESIDENT ALEKSANDER CEFERIN, CONCACAF…
(Refiles story to remove errant text in headline, with no changes to the body of…